claim: china issued an emergency use authorization for cellex qsars-cov-2 igg/igm rapid test
evidence_1: notably, the fda issued an emergency use authorization, on april 1, 2020, to cellex inc.s qsars-cov-2 igg/igm rapid test which is the first serology test to date to receive authorization to test for the presence of coronavirus antibodies.", "by dave muoio april 02, 2020 03:13 pm share editor's note: on the same day this story was published, the fda publicized the first emergency use authorization of a serology test,cellex inc.s qsars- cov-2 igg/igm rapid test.")